Your browser doesn't support javascript.
loading
Memory CD8+ T cell-mediated protection against liver-stage malaria.
Hassert, Mariah; Arumugam, Sahaana; Harty, John T.
Afiliación
  • Hassert M; Department of Pathology, University of Iowa-Carver College of Medicine, Iowa City, Iowa, USA.
  • Arumugam S; Department of Pathology, University of Iowa-Carver College of Medicine, Iowa City, Iowa, USA.
  • Harty JT; Medical Scientist Training Program, University of Iowa-Carver College of Medicine, Iowa City, Iowa, USA.
Immunol Rev ; 316(1): 84-103, 2023 07.
Article en En | MEDLINE | ID: mdl-37014087
ABSTRACT
Nearly half of the world's population is at risk of malaria, a disease caused by the protozoan parasite Plasmodium, which is estimated to cause more than 240,000,000 infections and kill more than 600,000 people annually. The emergence of Plasmodia resistant to chemoprophylactic treatment highlights the urgency to develop more effective vaccines. In this regard, whole sporozoite vaccination approaches in murine models and human challenge studies have provided substantial insight into the immune correlates of protection from malaria. From these studies, CD8+ T cells have come to the forefront, being identified as critical for vaccine-mediated liver-stage immunity that can prevent the establishment of the symptomatic blood stages and subsequent transmission of infection. However, the unique biological characteristics required for CD8+ T cell protection from liver-stage malaria dictate that more work must be done to design effective vaccines. In this review, we will highlight a subset of studies that reveal basic aspects of memory CD8+ T cell-mediated protection from liver-stage malaria infection.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Plasmodium / Vacunas contra la Malaria / Malaria Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Immunol Rev Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Plasmodium / Vacunas contra la Malaria / Malaria Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Immunol Rev Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos